Safety of transradial cardiac catheterization in patients with end-stage liver disease

Evan Jacobs, Vikas Singh, Abdulla Damluji, Neil R. Shah, Jessica L. Warsch, Ravi Ghanta, Paul Martin, Carlos E. Alfonso, Claudia A. Martinez, Mauro Moscucci, Mauricio G. Cohen

Research output: Contribution to journalArticle

Abstract

Background Transradial access may be advantageous for patients with end-stage liver disease (ESLD) who need to undergo left heart catheterization (LHC). We aimed to assess the safety of transradial cardiac catheterization in patients listed for orthotopic liver transplantation. Methods This is a retrospective analysis of consecutive adult patients with the diagnosis of ESLD, who underwent LHC via transradial access as part of a pre-operative liver transplantation evaluation. All the patients also underwent right heart catheterization (RHC) via brachial or femoral vein. The primary outcome measure was procedure-related major bleeding. Secondary outcomes included access site minor bleeding, in-hospital mortality, radial access failure, and acute kidney injury. Results A total of 82 consecutive patients with ESLD, who underwent LHC via transradial access, were enrolled in the study. All patients also underwent RHC (n = 45 via brachial and n = 37 via femoral vein). The median age was 59 (54, 67) years old, and 58% were male. History of coronary artery disease or heart failure was present in 17% of patients. The median MELD score was 19 (13, 24.5), baseline hemoglobin was 10.5 mg/dL (9.4, 11.8), INR was 1.4 (1.2, 1.8) and platelets were 74,000 (53,000, 117,000)/mm3. The most common etiology of liver failure was viral hepatitis (51%), followed by alcoholic cirrhosis (24%) and non-alcoholic steatohepatitis (21%). Angiographically significant coronary artery disease was present in 17 (21%) patients. Major bleeding and acute kidney injury each occurred in two patients (2.4%). There were no instances of vascular complications. There were no deaths attributable to complications from cardiac catheterization. Conclusion Upper extremity right and left heart catheterization appears to be a safe method to evaluate coronary anatomy and hemodynamics in a severely ill population of patients with ESLD awaiting transplant. © 2013 Wiley Periodicals, Inc.

Original languageEnglish (US)
Pages (from-to)360-366
Number of pages7
JournalCatheterization and Cardiovascular Interventions
Volume83
Issue number3
DOIs
StatePublished - Feb 15 2014
Externally publishedYes

Fingerprint

End Stage Liver Disease
Cardiac Catheterization
Safety
Femoral Vein
Hemorrhage
Acute Kidney Injury
Liver Transplantation
Coronary Artery Disease
Arm
Alcoholic Liver Cirrhosis
International Normalized Ratio
Liver Failure
Fatty Liver
Hospital Mortality
Upper Extremity
Hepatitis
Blood Vessels
Anatomy
Hemoglobins
Blood Platelets

Keywords

  • bleeding and transplant
  • cardiac catheterization
  • liver disease
  • transradial

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Jacobs, E., Singh, V., Damluji, A., Shah, N. R., Warsch, J. L., Ghanta, R., ... Cohen, M. G. (2014). Safety of transradial cardiac catheterization in patients with end-stage liver disease. Catheterization and Cardiovascular Interventions, 83(3), 360-366. https://doi.org/10.1002/ccd.25043

Safety of transradial cardiac catheterization in patients with end-stage liver disease. / Jacobs, Evan; Singh, Vikas; Damluji, Abdulla; Shah, Neil R.; Warsch, Jessica L.; Ghanta, Ravi; Martin, Paul; Alfonso, Carlos E.; Martinez, Claudia A.; Moscucci, Mauro; Cohen, Mauricio G.

In: Catheterization and Cardiovascular Interventions, Vol. 83, No. 3, 15.02.2014, p. 360-366.

Research output: Contribution to journalArticle

Jacobs, E, Singh, V, Damluji, A, Shah, NR, Warsch, JL, Ghanta, R, Martin, P, Alfonso, CE, Martinez, CA, Moscucci, M & Cohen, MG 2014, 'Safety of transradial cardiac catheterization in patients with end-stage liver disease', Catheterization and Cardiovascular Interventions, vol. 83, no. 3, pp. 360-366. https://doi.org/10.1002/ccd.25043
Jacobs, Evan ; Singh, Vikas ; Damluji, Abdulla ; Shah, Neil R. ; Warsch, Jessica L. ; Ghanta, Ravi ; Martin, Paul ; Alfonso, Carlos E. ; Martinez, Claudia A. ; Moscucci, Mauro ; Cohen, Mauricio G. / Safety of transradial cardiac catheterization in patients with end-stage liver disease. In: Catheterization and Cardiovascular Interventions. 2014 ; Vol. 83, No. 3. pp. 360-366.
@article{90584ddd675e4f3e969dc63cd3face75,
title = "Safety of transradial cardiac catheterization in patients with end-stage liver disease",
abstract = "Background Transradial access may be advantageous for patients with end-stage liver disease (ESLD) who need to undergo left heart catheterization (LHC). We aimed to assess the safety of transradial cardiac catheterization in patients listed for orthotopic liver transplantation. Methods This is a retrospective analysis of consecutive adult patients with the diagnosis of ESLD, who underwent LHC via transradial access as part of a pre-operative liver transplantation evaluation. All the patients also underwent right heart catheterization (RHC) via brachial or femoral vein. The primary outcome measure was procedure-related major bleeding. Secondary outcomes included access site minor bleeding, in-hospital mortality, radial access failure, and acute kidney injury. Results A total of 82 consecutive patients with ESLD, who underwent LHC via transradial access, were enrolled in the study. All patients also underwent RHC (n = 45 via brachial and n = 37 via femoral vein). The median age was 59 (54, 67) years old, and 58{\%} were male. History of coronary artery disease or heart failure was present in 17{\%} of patients. The median MELD score was 19 (13, 24.5), baseline hemoglobin was 10.5 mg/dL (9.4, 11.8), INR was 1.4 (1.2, 1.8) and platelets were 74,000 (53,000, 117,000)/mm3. The most common etiology of liver failure was viral hepatitis (51{\%}), followed by alcoholic cirrhosis (24{\%}) and non-alcoholic steatohepatitis (21{\%}). Angiographically significant coronary artery disease was present in 17 (21{\%}) patients. Major bleeding and acute kidney injury each occurred in two patients (2.4{\%}). There were no instances of vascular complications. There were no deaths attributable to complications from cardiac catheterization. Conclusion Upper extremity right and left heart catheterization appears to be a safe method to evaluate coronary anatomy and hemodynamics in a severely ill population of patients with ESLD awaiting transplant. {\circledC} 2013 Wiley Periodicals, Inc.",
keywords = "bleeding and transplant, cardiac catheterization, liver disease, transradial",
author = "Evan Jacobs and Vikas Singh and Abdulla Damluji and Shah, {Neil R.} and Warsch, {Jessica L.} and Ravi Ghanta and Paul Martin and Alfonso, {Carlos E.} and Martinez, {Claudia A.} and Mauro Moscucci and Cohen, {Mauricio G.}",
year = "2014",
month = "2",
day = "15",
doi = "10.1002/ccd.25043",
language = "English (US)",
volume = "83",
pages = "360--366",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Safety of transradial cardiac catheterization in patients with end-stage liver disease

AU - Jacobs, Evan

AU - Singh, Vikas

AU - Damluji, Abdulla

AU - Shah, Neil R.

AU - Warsch, Jessica L.

AU - Ghanta, Ravi

AU - Martin, Paul

AU - Alfonso, Carlos E.

AU - Martinez, Claudia A.

AU - Moscucci, Mauro

AU - Cohen, Mauricio G.

PY - 2014/2/15

Y1 - 2014/2/15

N2 - Background Transradial access may be advantageous for patients with end-stage liver disease (ESLD) who need to undergo left heart catheterization (LHC). We aimed to assess the safety of transradial cardiac catheterization in patients listed for orthotopic liver transplantation. Methods This is a retrospective analysis of consecutive adult patients with the diagnosis of ESLD, who underwent LHC via transradial access as part of a pre-operative liver transplantation evaluation. All the patients also underwent right heart catheterization (RHC) via brachial or femoral vein. The primary outcome measure was procedure-related major bleeding. Secondary outcomes included access site minor bleeding, in-hospital mortality, radial access failure, and acute kidney injury. Results A total of 82 consecutive patients with ESLD, who underwent LHC via transradial access, were enrolled in the study. All patients also underwent RHC (n = 45 via brachial and n = 37 via femoral vein). The median age was 59 (54, 67) years old, and 58% were male. History of coronary artery disease or heart failure was present in 17% of patients. The median MELD score was 19 (13, 24.5), baseline hemoglobin was 10.5 mg/dL (9.4, 11.8), INR was 1.4 (1.2, 1.8) and platelets were 74,000 (53,000, 117,000)/mm3. The most common etiology of liver failure was viral hepatitis (51%), followed by alcoholic cirrhosis (24%) and non-alcoholic steatohepatitis (21%). Angiographically significant coronary artery disease was present in 17 (21%) patients. Major bleeding and acute kidney injury each occurred in two patients (2.4%). There were no instances of vascular complications. There were no deaths attributable to complications from cardiac catheterization. Conclusion Upper extremity right and left heart catheterization appears to be a safe method to evaluate coronary anatomy and hemodynamics in a severely ill population of patients with ESLD awaiting transplant. © 2013 Wiley Periodicals, Inc.

AB - Background Transradial access may be advantageous for patients with end-stage liver disease (ESLD) who need to undergo left heart catheterization (LHC). We aimed to assess the safety of transradial cardiac catheterization in patients listed for orthotopic liver transplantation. Methods This is a retrospective analysis of consecutive adult patients with the diagnosis of ESLD, who underwent LHC via transradial access as part of a pre-operative liver transplantation evaluation. All the patients also underwent right heart catheterization (RHC) via brachial or femoral vein. The primary outcome measure was procedure-related major bleeding. Secondary outcomes included access site minor bleeding, in-hospital mortality, radial access failure, and acute kidney injury. Results A total of 82 consecutive patients with ESLD, who underwent LHC via transradial access, were enrolled in the study. All patients also underwent RHC (n = 45 via brachial and n = 37 via femoral vein). The median age was 59 (54, 67) years old, and 58% were male. History of coronary artery disease or heart failure was present in 17% of patients. The median MELD score was 19 (13, 24.5), baseline hemoglobin was 10.5 mg/dL (9.4, 11.8), INR was 1.4 (1.2, 1.8) and platelets were 74,000 (53,000, 117,000)/mm3. The most common etiology of liver failure was viral hepatitis (51%), followed by alcoholic cirrhosis (24%) and non-alcoholic steatohepatitis (21%). Angiographically significant coronary artery disease was present in 17 (21%) patients. Major bleeding and acute kidney injury each occurred in two patients (2.4%). There were no instances of vascular complications. There were no deaths attributable to complications from cardiac catheterization. Conclusion Upper extremity right and left heart catheterization appears to be a safe method to evaluate coronary anatomy and hemodynamics in a severely ill population of patients with ESLD awaiting transplant. © 2013 Wiley Periodicals, Inc.

KW - bleeding and transplant

KW - cardiac catheterization

KW - liver disease

KW - transradial

UR - http://www.scopus.com/inward/record.url?scp=84893477143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893477143&partnerID=8YFLogxK

U2 - 10.1002/ccd.25043

DO - 10.1002/ccd.25043

M3 - Article

VL - 83

SP - 360

EP - 366

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

IS - 3

ER -